Europe · Exchanges & live quotes · Finanzen.net
EQS-News: Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026
NEW YORK, October 29, 2026 – Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today…
Read the full article on Finanzen.net Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.finanzen.net)
